VYGR: Voyager Therapeutics, Inc. Company Short-Term Debt
Voyager Therapeutics (VYGR) is developing advanced treatments for brain pathologies, overcoming the complexities of delivering agents across the blood-brain barrier. This price chart demonstrates the asset's dynamics, where the separate_debt_short metric stands at 0.01. Possession of unique technologies for transporting genetic material into the CNS allows Voyager Therapeutics (VYGR) to forge strategic partnerships, ensuring sustainable growth without engaging in direct competition.
Analytical breakdowns and data insights for company Voyager Corp (VYGR)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Equity Ratio Voyager Therapeutics|VYGR - Long-Term Liabilities to Capital|Short-Term Debt to Capital Voyager Therapeutics|VYGR - Company Aggregate Debts|Debts to Book Capitalization Voyager Therapeutics, Inc.|VYGR - Long-Term Indebtedness|Company Short-Term Debts Voyager Therapeutics|Quick Liquidity voyagertherapeutics.com
- earnings and valuation multiples indicators:
Analysis of all company metrics:Voyager Therapeutics, Inc. (VYGR)
Voyager Therapeutics (VYGR) is developing gene therapies amidst fierce competition for delivery platforms. This short-term debt trend captures obligations maturing within one year, reflecting current liquidity. An increase in this metric signals a reliance on external loans coupled with the risk of contract terminations with big pharma behemoths. Investors must monitor this trend to assess solvency, as a sharp increase in debt raises the cost of capital.
Analysis of competing companies
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Current Liabilities ACAD|Company Short-Term Debt XENE|Company Short-Term Debt Viking Therapeutics, Inc. (VKTX)|SUPN - Short-Term Debt|Catalyst Pharmaceuticals Inc - Company Current Liabilities|Denali Corp (DNLI) - Short-Term Debt|Harmony Biosciences - Company Short-Term Debts|BHVN - Company Short-Term Debts|AMLX: Company Short-Term Debts|Short-Term Indebtedness Trevi Therapeutics Inc TRVI|PRAX (Praxis Medicines) - Company Short-Term Debts|Short-Term Debt Anavex Life Sciences Corp AVXL|Company Short-Term Debt CeriBell, Inc. (CBLL)|PRTA (Prothena Corporation plc) - Company Short-Term Loans and Borrowings|Alector - Company Current Liabilities|Company Short-Term Loans and Borrowings ANNX|OMER: Company Current Liabilities|Neurogene Therapeutics - Amount of Current Liabilities|ACIU: Company Short-Term Debts|neumoratx.com - Company Short-Term Loans and Borrowings|SCLX (Scilex) - Company Short-Term Debts|Short-Term Debt Tevogen Bio Holdings Inc. TVGN|Company Short-Term Debt Alpha Cognition (ACOG)|CGTX (cogrx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts IKT (Inhibikase Therapeutics)|Company Short-Term Debts cassavasciences.com SAVA|ASRT - Company Short-Term Debt|Current Liabilities COYA|VTGN: Company Short-Term Debts|Short-Term Debt Ovid Therapeutics (OVID)|Company Current Liabilities ABOS|Company Short-Term Debts cervomed.com|Company Current Liabilities ATHE (Alterity Therapeutics)|Amount of Current Liabilities CLNN|Company Short-Term Debts PEPG (PepGen)|Short-Term Debt Volume jupiterneurosciences.com (JUNS)|Relmada Therapeutics - Company Short-Term Debts|annovisbio.com (ANVS) - Company Current Liabilities|gracetx.com (GRCE) - Company Short-Term Debt|AIFF - Short-Term Debt Volume|Company Current Liabilities KLTO|Company Short-Term Debt NRSN|Company Current Liabilities RVPH (Reviva Pharmaceuticals)|MTVA - Short-Term Debt|Company Short-Term Debts NRXS (NeurAxis)|Short-Term Indebtedness Helius Medical Technologies, Inc.|PASG - Company Short-Term Debt|Company Short-Term Loans and Borrowings NEUP (Neuphoria Therapeutics Inc.)|Minerva Neurosciences (NERV) - Company Short-Term Debt|Company Short-Term Indebtedness ATHA|ADXN (Addex Therapeutics Ltd) - Company Short-Term Debts|Short-Term Debt Alzamend ALZN|Company Current Liabilities CYCN (Cyclerion Therapeutics)|Company Short-Term Debts protagenic.com (PTIX)|Company Short-Term Debt Pasithea Therapeutics Corp. KTTA|Company Short-Term Loans and Borrowings CRGT|ATXI - Company Short-Term Debt|Short-Term Debt Brainstorm Cell Therapeutics Inc.|CARA (Cara Therapeutics, Inc) - Company Current Liabilities|CHRO (Chromocell) - Company Short-Term Debt|Company Short-Term Debt Eliem Therapeutics, Inc.|Short-Term Debt Intra-Cellular ITCI|Company Current Liabilities LBPH (Longboard Pharmaceuticals, Inc.)|MRNS - Short-Term Debt|Company Short-Term Debts NKGN (NKGen)|Company Short-Term Debts NeuroBo Pharma NRBO|Sage Therapeutics, Inc. - Company Short-Term Debts|Short-Term Indebtedness synaptogen.com (SNPX)|TRVN: Company Short-Term Debts|Short-Term Debt Vigil Neuroscience, Inc. (VIGL)|Company Short-Term Debt Anew Medical, Inc.|CERE: Company Short-Term Loans and Borrowings